This proposal seeks 5 years of funding to continue the vitamin E (400 IU on alternate days), vitamin C (500 mg daily), and multivitamin (Centrum Silver daily) components of the Physicians' Health Study (PHS) II, extending average treatment and follow-up from 3.7 to 8.2 years. The PHS Ills an ongoing randomized, double-blind, placebo-controlled trial using a factorial design to evaluate the roles of Vitamin E, vitamin C, a multivitamin, and p-carotene in chronic disease prevention among 14,642 U.S. male physicians aged 50 years and older who have demonstrated excellent morbidity and mortality follow-up and high compliance. The PHS Ills uniquely positioned to clarify ambiguities regarding the roles of vitamin E in the primary prevention of prostate cancer and cardiovascular disease (CVD) among those at usual risk; the role of a multivitamin and vitamin C in the prevention of cancer and CVD; and all three agents in the prevention of eye disease and declines in cognitive function. After reviewing the progress of the trial and the unblinded data, the Data and Safety Monitoring Board unanimously recommended an extension beyond the trial's scheduled termination of funding in December 2002. The primary rationale for the Board's recommendation was the likelihood, at the end of current funding, of ambiguous results due to insufficient numbers of endpoints and an inadequate latent period, which they feared could result in considerable clinical confusion. Because recruitment and 3.7 years of treatment and follow-up have been supported by nearly $20,000,000 of industry funds, the proposal to extend PHS II represents an extremely cost-efficient way to provide either clear positive or definitive null results on which sound clinical and public health recommendations can be Dased for the use of these commonly consumed vitamin supplements. Given the gaps in knowledge this study is intended to address, we believe the proposed extension of this primary prevention trial in men at usual risk is timely, important, and will complement other ongoing clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA097193-04
Application #
6943033
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Parnes, Howard L
Project Start
2002-09-30
Project End
2007-08-31
Budget Start
2005-09-01
Budget End
2006-08-31
Support Year
4
Fiscal Year
2005
Total Cost
$1,611,803
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
Christen, William G; Cook, Nancy R; Chiuve, Stephanie E et al. (2018) Prospective study of plasma homocysteine, its dietary determinants, and risk of age-related macular degeneration in men. Ophthalmic Epidemiol 25:79-88
FitzGerald, L M; Zhao, S; Leonardson, A et al. (2018) Germline variants in IL4, MGMT and AKT1 are associated with prostate cancer-specific mortality: An analysis of 12,082 prostate cancer cases. Prostate Cancer Prostatic Dis 21:228-237
Pettersson, Andreas; Gerke, Travis; Penney, Kathryn L et al. (2018) MYC Overexpression at the Protein and mRNA Level and Cancer Outcomes among Men Treated with Radical Prostatectomy for Prostate Cancer. Cancer Epidemiol Biomarkers Prev 27:201-207
Ashar, Foram N; Mitchell, Rebecca N; Albert, Christine M et al. (2018) A comprehensive evaluation of the genetic architecture of sudden cardiac arrest. Eur Heart J 39:3961-3969
Patel, Yash R; Gadiraju, Taraka V; Gaziano, J Michael et al. (2018) Adherence to healthy lifestyle factors and risk of death in men with diabetes mellitus: The Physicians' Health Study. Clin Nutr 37:139-143
Butt, Julia; Blot, William J; Teras, Lauren R et al. (2018) Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium. Cancer Epidemiol Biomarkers Prev 27:1186-1194
Orkaby, Ariela R; Gaziano, J Michael; Djousse, Luc et al. (2017) Statins for Primary Prevention of Cardiovascular Events and Mortality in Older Men. J Am Geriatr Soc 65:2362-2368
Orkaby, Ariela R; Hshieh, Tammy T; Gaziano, John M et al. (2017) Comparison of two frailty indices in the physicians' health study. Arch Gerontol Geriatr 71:21-27
Patel, Ravi B; Moorthy, M V; Chiuve, Stephanie E et al. (2017) Hemoglobin A1c levels and risk of sudden cardiac death: A nested case-control study. Heart Rhythm 14:72-78
Campbell, Peter T; Newton, Christina C; Kitahara, Cari M et al. (2017) Body Size Indicators and Risk of Gallbladder Cancer: Pooled Analysis of Individual-Level Data from 19 Prospective Cohort Studies. Cancer Epidemiol Biomarkers Prev 26:597-606

Showing the most recent 10 out of 233 publications